Skip to main content
Log in

The role of NT-proBNP in the diagnostics and differentiation of cardiac and reflex syncope in adults: relative importance to clinical presentation and medical examinations

  • Published:
Journal of Interventional Cardiac Electrophysiology Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to assess the clinical significance of N-terminal pro-B-type natriuretic peptide (NT-proBNP) concentrations in the differentiation of patients with cardiac and reflex syncope.

Methods

The study included a group of 100 patients (56 women, 44 men), aged 18–77 years (mean 52.6 ± 16.7), with a history of reflex (group I) or cardiac syncope (group II). Diagnosis of syncope was performed according to the European Society of Cardiology (ESC) guidelines. In all patients, the concentration of NT-proBNP was measured.

Results

The assessment of NT-proBNP concentrations showed significantly higher concentrations in group II than in group I (448.7 ± 212.2 vs. 68.2 ± 64.1 pg/ml, P < 0.0001). The receiver operating characteristic (ROC) curve analysis revealed that the concentration of NT-proBNP at 210.5 pg/ml may be a useful cut-off point which allows the prediction of cardiac syncope with 98 % specificity, 94 % sensitivity, and 94 % negative predictive value. In patients with cardiac arrhythmias and conduction abnormalities, the concentrations of NT-proBNP were higher in comparison to those without such disorders.

Conclusions

The concentration of NT-proBNP is useful in the diagnosis of syncope and may initially guide the diagnostic process. The NT-proBNP value exceeding 200 pg/ml seems to be the most rational in determining cardiac syncope.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Moya, A., Sutton, R., Ammirati, F., Blanc, J. J., Brignole, M., Dahm, J. B., et al. (2009). Guidelines for the diagnosis and management of syncope (version 2009). The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC). European Heart Journal, 30(21), 2631–2671.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Huff, J. S., Decker, W. W., Quinn, J. V., Perron, A. D., Napoli, A. M., Peeters, S., et al. (2007). Clinical policy: critical issues in the evaluation and management of adult patients presenting to the emergency department with syncope. Annals of Emergency Medicine, 49(4), 431–444.

    Article  PubMed  Google Scholar 

  3. Soteriades, E. S., Evans, J. C., Larson, M. G., Chen, M. H., Chen, L., Benjamin, E. J., et al. (2002). Incidence and prognosis of syncope. New England Journal of Medicine, 347(12), 878–885.

    Article  PubMed  Google Scholar 

  4. Rademaker, M. T., & Richards, A. M. (2005). Cardiac natriuretic peptides for cardiac health. Clinical Science, 108(1), 23–36.

    Article  PubMed  CAS  Google Scholar 

  5. Fitzpatrick, A. P., Theodorakis, G., Vardas, P., & Sutton, R. (1991). Methodology of head-up tilt testing in patients with unexplained syncope. Journal of the American College of Cardiology, 17(1), 125–130.

    Article  PubMed  CAS  Google Scholar 

  6. Crawford, M. H., Bernstein, S. J., Deedwania, P. C., DiMarco, J. P., Ferrick, K. J., Garson, A., et al. (1999). ACC/AHA guidelines for ambulatory electrocardiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the Guidelines for Ambulatory Electrocardiography) developed in collaboration with the North American Society for Pacing and Electrophysiology. Journal of the American College of Cardiology, 34(3), 912–948.

    Article  PubMed  CAS  Google Scholar 

  7. Cheitlin, M. D., Armstrong, W. F., Aurigemma, G. P., Beller, G. A., Bierman, F. Z., Davis, J. L., et al. (2003). ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Journal of the American College of Cardiology, 42(5), 954–970.

    Article  PubMed  Google Scholar 

  8. Freitag, M. H., Larson, M. G., Levy, D., Benjamin, E. J., Wang, T. J., Leip, E. P., et al. (2003). Plasma brain natriuretic peptide levels and blood pressure tracking in the Framingham Heart Study. Hypertension, 41(4), 978–983.

    Article  PubMed  CAS  Google Scholar 

  9. Lellouche, N., Berthier, R., Mekontso-Dessap, A., Braconnier, F., Monin, J. L., Duval, A. M., et al. (2005). Usefulness of plasma B-type natriuretic peptide in predicting recurrence of atrial fibrillation one year after external cardioversion. The American Journal of Cardiology, 95(11), 1380–1382.

    Article  PubMed  CAS  Google Scholar 

  10. Seino, Y., Ogawa, A., Yamashita, T., Fukushima, M., Ogata, K. I., Fukumoto, H., & Takano, T. (2004). Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. European Journal of Heart Failure, 6(3), 295–300.

    Article  PubMed  CAS  Google Scholar 

  11. Stryjewski, P. J., Nessler, B., Cubera, K., & Nessler, J. (2013). Natriuretic peptides. History of discovery, chemical structure, mechanism of action and the removal routes. Basis of diagnostic and therapeutic use. Przegla̧d Lekarski, 70(7), 463–467.

    PubMed  Google Scholar 

  12. Stryjewski, P. J., Nessler, B., Matusik, P., Badacz, L., Nowak, J., & Nessler, J. (2014). Natriuretic peptides and their use in clinical practice according to the guidelines of the European Society of Cardiology. Przeglad Lekarski, 71(1), 33–35.

  13. Torbicki, A., Perrier, A., Konstantinides, S., Agnelli, G., Galiè, N., Pruszczyk, P., et al. (2008). Guidelines on the diagnosis and management of acute pulmonary embolism. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). European Heart Journal, 29(18), 2276–2315.

    Article  PubMed  CAS  Google Scholar 

  14. Lim, P., Monin, J. L., Monchi, M., Garot, J., Pasquet, A., Hittinger, L., et al. (2004). Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. European Heart Journal, 25(22), 2048–2053.

    Article  PubMed  CAS  Google Scholar 

  15. McMurray, J. J., Adamopoulos, S., Anker, S. D., Auricchio, A., Böhm, M., Dickstein, K., et al. (2012). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. European Heart Journal, 33(14), 1787–1847.

    Article  PubMed  Google Scholar 

  16. N-terminal pro B-type natriuretic peptide. Cobas. Resource document. Roche Canada. http://www.rochecanada.com/fmfiles/re7234008/package_inserts/04842464190-ProBNPII-V8-English.pdf

  17. Tanimoto, K., Yukiiri, K., Mizushige, K., Takagi, Y., Masugata, H., Shinomiya, K., et al. (2004). Usefulness of brain natriuretic peptide as a marker for separating cardiac and noncardiac causes of syncope. The American Journal of Cardiology, 93(2), 228–230.

    Article  PubMed  CAS  Google Scholar 

  18. Pfister, R., Diedrichs, H., Larbig, R., Erdmann, E., & Schneider, C. A. (2009). NT-pro-BNP for differential diagnosis in patients with syncope. International Journal of Cardiology, 133(1), 51–54.

    Article  PubMed  Google Scholar 

  19. Pfister, R., Hagemeister, J., Esser, S., Hellmich, M., Erdmann, E., & Schneider, C. A. (2012). NT-pro-BNP for diagnostic and prognostic evaluation in patients hospitalized for syncope. International Journal of Cardiology, 155(2), 268–272.

    Article  PubMed  Google Scholar 

  20. Kapoor, W. N., Karpf, M., Wieand, S., Peterson, J. R., & Levey, G. S. (1983). A prospective evaluation and follow-up of patients with syncope. New England Journal of Medicine, 309(4), 197–204.

    Article  PubMed  CAS  Google Scholar 

  21. Sarasin, F. P., Louis-Simonet, M., Carballo, D., Slama, S., Rajeswaran, A., Metzger, J. T., et al. (2001). Prospective evaluation of patients with syncope: a population-based study. The American Journal of Medicine, 111(3), 177–184.

    Article  PubMed  CAS  Google Scholar 

  22. Reed, M. J., Newby, D. E., Coull, A. J., Prescott, R. J., Jacques, K. G., & Gray, A. J. (2010). The ROSE (risk stratification of syncope in the emergency department) study. Journal of the American College of Cardiology, 55(8), 713–721.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Piotr J. Stryjewski.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stryjewski, P.J., Nessler, B., Kuczaj, A. et al. The role of NT-proBNP in the diagnostics and differentiation of cardiac and reflex syncope in adults: relative importance to clinical presentation and medical examinations. J Interv Card Electrophysiol 41, 1–8 (2014). https://doi.org/10.1007/s10840-014-9923-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10840-014-9923-x

Keywords

Navigation